Skip to main content

Table 1 Classification of the samples studied by age and clinical characteristics (n = 1300)

From: Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

Clinical characteristic

Number of patients (%)

Gender

 Male

593 (45.6)

 Female

707 (54.4%)

Age at diagnosis

 Median (range)

63 (19–90)

Tumor type

 Colorectal

354 (27.2%)

 Lung

223 (17.2%)

 Breast

172 (13.2%)

 Prostate

83 (6.4%)

 Melanoma

65 (5%)

 Lymphoma

49 (3.8%)

 Gastric

45 (3.5%)

 Head and neck

45 (3.5%)

 Bladder

38 (2.9%)

 Ocular melanoma

32 (2.5%)

 Endometrial

29 (2.2%)

 Kidney

28 (2.2%)

 Ovary

24 (1.8%)

 Brain

24 (1.8%)

 Oesophagus

22 (1.7%)

 Pancreas

19 (1.5%)

 Liver

16 (1.2%)

 Testis

16 (1.2%)

 Thyroid

13 (1%)

 Sarcoma

3 (0.2%)

Origin of the tumors

 Primary tumor

1166 (89.7%)

 Metastasis

44 (3.4%)

 Unknown

90 (6.9%)